BioWorld

Varian receives FDA 510(k), CE mark for Halcyon and Ethos radiotherapy systems with Hypersight

Varian’s Halcyon and Ethos radiotherapy systems received two regulatory nods in short succession, with both U.S. FDA 510(k) clearance and CE marking. In addition, the company reported that the first ...
WDTN

Varian Receives FDA 510(k) Clearance for Halcyon and Ethos Radiotherapy Systems Featuring HyperSight Imaging Solution and Announces First Patient Treatment

PALO ALTO, Calif., Feb. 2, 2023 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well ...
MarketWatch

Varian Elevates Halcyon Platform by Redefining the Patient Experience

The MarketWatch News Department was not involved in the creation of this content. -- The new PerfectKinetix Dynamic Couch* accelerates patient positioning, and aims to improve comfort -- IDENTIFY* ...
Longview News-Journal

New equipment at Texas Oncology in Longview allows for more ‘aggressive, efficient’ cancer treatment

Texas Oncology – Longview Cancer Center recently began using new technology its leaders say will allow more aggressive and efficient radiation treatments. The Halcyon System, with HyperSight, is a ...
Yahoo Finance

Sainte Catherine, Institut du Cancer Avignon-Provence (ICAP), Becomes the First Center in Europe to Implement the Varian Latest Halcyon Advancements with Identify integration ...

AVIGNON, France, December 10, 2025--(BUSINESS WIRE)--Institut du Cancer Avignon-Provence (ICAP), and Varian, a Siemens Healthineers company, announced today the first European installation of the ...